Home
Halozyme

Halozyme Market Share Analysis for November 2025

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

Health > Biotechnology and Pharmaceuticals

Domainhalozyme.com

Year Founded1998

Employees201 - 500

Annual Revenue> $1B

Halozyme

Showing Halozyme's traffic and engagement information for its main website (including company regionals)

halozyme.com
scaune.ro

See more website traffic and engagement information

Halozyme Revenue up to November 2025 is > 1B

revenue generated by Halozyme top domains

Halozyme top domains revenue over 3 years

Revenue for Halozyme top domains

halozyme.com> 1B

scaune.ro10M - 15M

See more with Sales Intelligence

Total visits to Halozyme's top domains

Understand Halozyme market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

halozyme.com7.8K

scaune.ro2.9K

See more with Sales Intelligence

Avg. visit duration in Halozyme's top domains

Analyze Halozyme engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

halozyme.com00:00:36

scaune.ro00:00:26

See more with Sales Intelligence

Avg. pageviews on Halozyme's top domains

See how Halozyme keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

halozyme.com2.13

scaune.ro2.33

See more with Sales Intelligence

Halozyme top competitors by domain

Top similar sites in November 2025, ranked by their affinity

arenapharm.comCompany NameArena Pharmaceuticals, Inc.Employees201 - 500HQUnited States, California, San DiegoAnnual revenue> $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Halozyme

These are the website technologies, by industry, used by Halozyme top domains

Social (4)

Facebook Social Plugins

Widget (4)

Twemoji

Conversion & Analytics (3)

Google Analytics

Advertising (2)

DoubleClick

More Technologies

10

See all

News & Signals from Halozyme

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHalozyme Therapeutics, Inc. is developing subcutaneous formulation of petosemtamab.Merus, Halozyme partner to develop subcutaneous formulation of petosemtamab.

NewsHalozyme Therapeutics, Inc. receives financing of $1.3B.Halozyme Therapeutics raises $1.3B via convertible notes to refinance debt and fund growth.

NewsHalozyme Therapeutics, Inc. is planning to acquire Elektrofi Inc. for $750M.In a bold strategic step, Halozyme Therapeutics announced its agreement to acquire Boston-based drug delivery innovator Elektrofi for $750 million...